Complement component C3: Serologic signature for osteogenesis imperfecta. Analysis of a comparative proteomic study
Shu-Jui Kuo1, Feng-Sheng Wang2, Jiunn-Ming Sheen3
1Department of Orthopedic Surgery, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|March 12, 2014
Summary
This study identified novel serum protein biomarkers, including complement component C3 (C3), for osteogenesis imperfecta (OI). Elevated haptoglobin (HP) and decreased C3 and vitamin D-binding protein (DBP) levels are associated with OI, with C3 correlating to bone density.
Area of Science:
- Biochemistry
- Genetics
- Orthopedics
Background:
- Osteogenesis imperfecta (OI) is a genetic disorder characterized by compromised bone strength, leading to increased fracture risk.
- Current diagnostic methods for OI primarily rely on clinical and radiographic assessments, with limited specific serological markers.
Purpose of the Study:
- To investigate serum proteomic profiles in individuals with OI.
- To identify potential serum protein biomarkers for OI diagnosis and assessment.
- To explore the correlation between identified serum proteins and bone mineral density in OI patients.
Main Methods:
- Comparative serum proteomic analysis using two-dimensional electrophoresis and tandem mass spectrometry in 20 OI patients and 20 controls.
- Enzyme-linked immunosorbent assay (ELISA) for quantifying specific protein levels: complement component C3 (C3), vitamin D-binding protein (DBP), and haptoglobin (HP).
- Receiver operating characteristic (ROC) curve analysis to determine diagnostic accuracy and correlation analysis with bone mineral density (BMD) in OI patients.
Main Results:
- Complement component C3 (C3), vitamin D-binding protein (DBP), and haptoglobin (HP) were identified as candidate serum proteins in OI.
- OI patients exhibited significantly lower serum levels of C3 and DBP, and higher levels of HP compared to controls.
- Serum C3 levels demonstrated a significant positive correlation with bone mineral density in the lumbar spine and hip of OI patients.
- C3 showed the highest area under the curve (AUC) in ROC analysis, indicating superior ability to differentiate OI from healthy individuals.
Conclusions:
- Serum C3, DBP, and HP represent potential novel serological biomarkers for osteogenesis imperfecta.
- Serum C3 concentration is a valuable indicator that correlates with bone mineral density T-scores in OI patients.
- C3 exhibits the strongest diagnostic potential among the evaluated proteins for distinguishing OI from healthy controls.
More Related Videos
Related Concept Videos
01:27Complement System
10.6K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.6K
01:33Proteomics
7.5K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.5K